Navigation Links
Poniard Pharmaceuticals Announces Upcoming Conference Participation
Date:5/1/2008

SOUTH SAN FRANCISCO, Calif., May 1 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced that Jerry McMahon, Ph.D., chairman and CEO, will participate in two upcoming conferences in May:

-- The Leerink Swann "Conquering Cancer with Novel Therapeutics"

Roundtable Conference on May 9 at 1:35 p.m. Eastern Time at the Grand

Hyatt New York

-- The CitiGroup Health Care Conference on May 21 at 9:30 a.m. Eastern

Time at the New York Hilton

A live audio webcast of the presentation at CitiGroup will be available for 10 business days on the "Events" page of the "News & Events" section of the Company's website at http://www.poniard.com.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. Picoplatin, the Company's lead platform product candidate, is a new generation platinum therapy with an improved safety profile relative to existing platinum-based cancer therapies. Picoplatin is designed to overcome platinum resistance associated with chemotherapy in solid tumors, and is being studied in multiple cancer indications, combinations and formulations. Clinical trials of intravenous picoplatin include a Phase 3 trial in small cell lung cancer and Phase 2 trials in metastatic colorectal and hormone-refractory prostate cancers, as well as a Phase 1 clinical trial of oral picoplatin in solid tumors. Picoplatin has not been approved by any regulatory authority for use in humans. For additional inform
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
2. Poniard Pharmaceuticals Announces Upgrade of Stock Listing to NASDAQ Global Market
3. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
5. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
11. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... , , BEIJING, Nov. 25 /PRNewsw...g developer and provider of vaccines, announced to...t to establish Sinovac (Dalian) Vaccine,Technology... develop, produce,and commercialize human-use vacc...perience in developing and commercializing world-c...
(Date:11/24/2009)... , Ambassador to also Vis...mber 24, 2009 -- , , ,Who: David Appia, French Amb... and CEO of the Invest in France Agency, , , , ,W...ess to discuss recent pro-business initiatives ado...iscal and academic landscape for innovation and de...
(Date:11/24/2009)... , , ST. LOUIS, Nov. 24 /PRNewswire-Fi...AL ) will be presenting at the NASDAQ OMX conferen...on, 7:45 AM US/CST. Interested parties may listen ...le at http://inve s tor.sig m a a ldrich.c...ss this file. ,, About Sigma-Aldrich: Sig...
(Date:11/24/2009)... , , SHANGHAI, Nov. 24 /PRNewswi... State Food & Drug Administration (SFDA) has a...IND) for its oral insulin project,(Nodlin), an inn...s IND,approval allows Biolaxy to initiate its firs... disorder characteristic of high blood glucose and...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Biolaxy Secures IND Approval for Oral Insulin 2
...aq: NXXI ), a growing developer and marketer of n...tes Essentials(TM) and Iceland Health(R) brands,th...ve cardiovascular,health, enhance memory, and addr...lts for the second quarter of fiscal year 2008, en..., after market close. The,Company has scheduled a ...
...) Brett Begemann, executive vice president of glob... vice president of strategy and,operations, will a...conferences later this month., Both Monsanto exec...iness performance and expectations, strategic init...ment pipeline, and other business matters,at these...
...n Company,s web site, GERMANTOWN, Md., Feb. 5 Mi...a pharmaceutical company focused on,developing and...day,announced that Dr. Edward M. Rudnic, MiddleBro...sentation on Monday, February 11, 2008, at 11:45,a...ce as part of the Biotechnology Industry,Organizat...
Other Biology Technology:Nutrition 21 to Report Second Quarter Fiscal 2008 Financial Results Monday, February 11, 2008 2MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008 2
(Date:11/26/2009)... , MRSA (methicillin-resistant Staphylococcus Au...e annihilation as low-temperature plasma prototype... easy and unfailing bactericidal cocktails. , Tw...fficient disinfection of healthy skin (e.g. hands ...teria can pose a lethal threat; and another to sho...
(Date:11/25/2009)... , On September 11, firefighters, police officers...ffort in the World Trade Center complex. They batt..., searched for survivors, tackled fires and evacua...contained an estimated 17,000 people. And making t...unications: frightened workers and their relatives...
(Date:11/25/2009)... , Two Kent State University assistant professors...ce Foundation (NSF) to continue research beneficia...ts total $890,000. , Christopher Blackwood, assi...iences, was awarded grants to support two separate..."Assembling Litter Decomposer Communities and Func...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3Kent State University professors focus research on the environment with grants totaling $890,000 2Cold Spring Harbor Laboratory 26apos 3Bs President Congratulates Alumna on Winning Nobel Prize 58919 1Cold Spring Harbor Laboratory 26apos 3Bs President Congratulates Alumna on Winning Nobel Prize 58919 2The American Academy of Family Physicians Launches Consumer Alliance With First Partner 3A The Coca Cola Company 58914 1The American Academy of Family Physicians Launches Consumer Alliance With First Partner 3A The Coca Cola Company 58914 2The American Academy of Family Physicians Launches Consumer Alliance With First Partner 3A The Coca Cola Company 58914 3The American Academy of Family Physicians Launches Consumer Alliance With First Partner 3A The Coca Cola Company 58914 4Sosei Assigns AD 923 Assets to Pharmasol 5243 1Sosei Assigns AD 923 Assets to Pharmasol 5243 2
...here Alzheimer,s, some cancers and genetic ills be...uncovered the pivotal role of a gene called "Cut" ...ommunication. , A DNA-binding protein, Cut interpr... through the "Notch" gene, which regulates a layer... But when Cut garbles those signals the result is ...
...iety of forms: particles, tubes, shells, even a so...ix: "nano," connoting their size, a billionth of a...y, cancer researchers are exploring the potential ...r cells without harming surrounding tissue, and to...ve a chance to become life-threatening. , While ...
...th an extra set of chromosomes can initiate the de...arber Cancer Institute have shown, validating a co...h by a scientific visionary nearly 100 years ago. ...by random errors in cell division that occur with ...ally unstable cells appears to be a "pathway for g...
Other Biology News:FSU biologists describe key role of signal-transcribing gene during cell cycle 2Nanoparticles, nanoshells, nanotubes: How tiny specks may provide powerful tools against cancer 2Nanoparticles, nanoshells, nanotubes: How tiny specks may provide powerful tools against cancer 3Nanoparticles, nanoshells, nanotubes: How tiny specks may provide powerful tools against cancer 4Nanoparticles, nanoshells, nanotubes: How tiny specks may provide powerful tools against cancer 5Nanoparticles, nanoshells, nanotubes: How tiny specks may provide powerful tools against cancer 6Nanoparticles, nanoshells, nanotubes: How tiny specks may provide powerful tools against cancer 7Nanoparticles, nanoshells, nanotubes: How tiny specks may provide powerful tools against cancer 8Double trouble: Cells with duplicate genomes can trigger tumors 2Double trouble: Cells with duplicate genomes can trigger tumors 3
...o be "a delight to use" as it incorporates the fun...ng. With its ergonomic design and small footprint,...accommodated in a busy lab environment. The DM-BA3...cted Infinity System and infinity-corrected Plan o...
...ighest resolution standard for all Imaging Plate e...AS scanners, it features a superior Imaging Plate ...tility in target subjects. Fujifilm BAS-5000 does ...ighest resolution results are available immediatel...
Anti-human CD41 Tetramer, 200 uL from StemCell Technologies, Inc.
... use and rapid solutions to meet your laboratory's...rol. ...is the standard software for Staccato Systems and ...erface with more than 100 laboratory devices. It i...
Biology Products: